KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $842.0 million.

  • Thermo Fisher Scientific's Non-Current Deferred Tax Liability fell 2502.23% to $842.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $842.0 million, marking a year-over-year decrease of 2502.23%. This contributed to the annual value of $1.3 billion for FY2024, which is 3402.71% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Non-Current Deferred Tax Liability stood at $842.0 million for Q3 2025, which was down 2502.23% from $624.0 million recorded in Q2 2025.
  • Thermo Fisher Scientific's Non-Current Deferred Tax Liability's 5-year high stood at $3.8 billion during Q4 2021, with a 5-year trough of $624.0 million in Q2 2025.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $1.9 billion (2021), whereas its average is $2.1 billion.
  • In the last 5 years, Thermo Fisher Scientific's Non-Current Deferred Tax Liability surged by 11433.45% in 2022 and then tumbled by 5883.91% in 2025.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Non-Current Deferred Tax Liability stood at $3.8 billion in 2021, then fell by 25.75% to $2.8 billion in 2022, then plummeted by 32.54% to $1.9 billion in 2023, then crashed by 34.03% to $1.3 billion in 2024, then tumbled by 33.6% to $842.0 million in 2025.
  • Its last three reported values are $842.0 million in Q3 2025, $624.0 million for Q2 2025, and $1.0 billion during Q1 2025.